US Executive Officer Management Changes SEC — April 10, 2026

10-04-2026

NexMetals Mining Corp. announced mining engineer Keith Marshall, with 45+ years experience including senior roles at Rio Tinto's Palabora and Oyu Tolgoi, as a Board nominee for the May 27, 2026 AGM, intending to appoint him to the Safety, Sustainability and Technical Committee. Directors Chris Leavy and James Gowans will not stand for re-election, while the remaining seven incumbents are renominated. In connection with investor relations services, the Company granted 44,800 incentive stock options to Nisha Hasan at $3.30 exercise price.

• ·Options exercisable for five years and vest over 12 months with one-quarter every three months.
• ·Management Information Circular to be mailed soon and available on SEDAR+.
• ·Company focused on redeveloping Selebi and Selkirk copper-nickel-cobalt-PGE mines in Botswana with NI 43-101 and Regulation S-K 1300-compliant resources.

10-04-2026

Royale Energy, Inc. (OTC: ROYL) appointed Micheal McCaskey, age 71, to its Board of Directors effective April 10, 2026. Mr. McCaskey brings over 35 years of experience in petroleum geology, exploration, and field development, including prior roles as President of Matrix Oil Management Corporation from Q1 2006 to April 2018 and service on Matrix Oil Corp.'s board since 1999. He currently serves on the board of RMX Resources, LLC and as President of PEM Management Corporation since February 2002.

• ·Mr. McCaskey served as Vice President and Secretary of Matrix Oil Corp. from 2002 to April 2018.
• ·Appointment announced in Form 8-K filed April 10, 2026, under Items 5.02 and 9.01.

10-04-2026

Camping World Holdings, Inc. filed an 8-K on April 10, 2026, disclosing Second Amended and Restated Employment Agreements effective January 1, 2026, for Thomas E. Kirn and Lindsey J. Christen with the company and CWGS Enterprises, LLC under Item 5.02. The filing includes exhibits for these agreements (10.1 and 10.2), a Form of Performance Stock Unit Award Grant Notice and Agreement (10.3), and Inline XBRL (104). The report was signed by Lindsey J. Christen, Chief Administrative and Legal Officer.

10-04-2026

On April 6, 2026, The Brink’s Company appointed Adnane Louridi as Senior Vice President and Global Controller, designating him as the Principal Accounting Officer. Mr. Louridi, age 42, joins from roles as Vice President and CFO, Global Automotive at TE Connectivity (2024-2026) and CFO, HVAC at Johnson Controls (2020-2024). He will receive standard executive compensation, with no family relationships to directors/officers or reportable related-party transactions.

• ·Filing submitted on April 10, 2026, signed by Kurt B. McMaken.
• ·Mr. Louridi eligible for annual base salary, annual/long-term incentives, and general executive benefits as determined by Compensation and Human Capital Committee.

10-04-2026

On April 6, 2026, John D. Gass notified Expand Energy Corporation that he will not stand for re-election to the Board of Directors at the 2026 Annual Meeting of Shareholders and will retire at its conclusion. His decision was not due to any disagreement with the Company regarding operations, policies, or practices. The company is listed on The Nasdaq Stock Market LLC under the ticker EXE.

• ·Form 8-K filed on April 10, 2026, reporting the event of April 6, 2026.
• ·Company incorporated in Oklahoma, Commission File Number 001-13726, IRS EIN 73-1395733.

10-04-2026

On April 7, 2026, Pamella J. Dana, a member of the Board of Directors of Amerant Bancorp Inc., notified the company that she will not seek reelection at the upcoming 2026 Annual Meeting of Shareholders, with her decision not resulting from any disagreement on operations, policies, or practices. Dr. Dana will serve until the end of her current term immediately before the Annual Meeting. Effective immediately before the Annual Meeting, the Board size will reduce from 12 to 11 directors.

• ·Filing submitted on April 10, 2026, for event dated April 7, 2026.
• ·Item 9.01 includes Exhibit 10.4: Cover Page Interactive Data File.

10-04-2026

On April 7, 2026, four members of Cypherpunk Technologies Inc.'s Board of Directors—Dr. Christopher Mirabelli and Dr. Joseph Loscalzo (Class III directors), and Dr. Richard Schilsky and Dr. James Cavanaugh (Class I directors)—notified the company of their intent to retire effective immediately prior to the 2026 Annual Meeting of Stockholders. None of the departures are due to any disagreement with the company's operations, policies, or practices. The Board thanked the retiring directors for their service and contributions.

• ·Retirements effective immediately prior to the 2026 Annual Meeting of Stockholders
• ·Registrant incorporated in Delaware, Commission File Number 001-37990, IRS EIN 27-4412575
• ·Common Stock (par value $0.001) trades as CYPH on The Nasdaq Capital Market
• ·Principal executive offices at 47 Thorndike Street, Suite B1-1, Cambridge, MA 02141

10-04-2026

Immunic, Inc. entered into a Retention Bonus Agreement with CEO Daniel Vitt on April 7, 2026, as the company begins searching for a new CEO with commercial expertise in multiple sclerosis to lead commercialization efforts. Mr. Vitt, who may transition to a C-Suite role focused on scientific strategy, is eligible for a $670,000 retention bonus if he remains employed through the 91st day after the new CEO's hire or upon certain terminations. The agreement includes mutual non-disparagement covenants but does not alter his existing employment terms.

• ·Retention bonus payable on first regular pay date after retention date or within 5 days of qualifying termination
• ·Bonus amount credited against any future severance under US Employment Agreement (Jan 1, 2026) or German Service Agreement (Dec 18, 2023)
• ·Agreement governed by New York law with arbitration provisions under AAA Employment Rules

10-04-2026

On April 8, 2026, PodcastOne, Inc. amended its 2022 Equity Incentive Plan to increase the maximum aggregate shares of common stock available for issuance from 2,000,000 to 4,000,000 shares, subject to stockholder approval at the 2026 annual meeting. The amendment, previously approved by the board, was executed by CFO Ryan Carhart and filed as Exhibit 10.1. No other changes to officer compensation or departures were reported.

• ·Common stock has $0.00001 par value per share and trades on The NASDAQ Capital Market under symbol PODC.
• ·Company confirmed as emerging growth company.
• ·Amendment effective upon stockholder approval.

10-04-2026

Remitly Global, Inc. (NASDAQ: RELY) appointed technology veteran Adam Messinger, former CTO of Twitter (now X) and director at New Relic, to its Board of Directors on April 10, 2026, increasing the board size from 10 to 11 members. Mr. Messinger also joins the Talent and Compensation Committee, bringing over 20 years of experience in software development and technical leadership from roles at Oracle and as advisor to Chime. CEO Sebastian Gunningham emphasized Messinger's expertise as instrumental for Remitly's expansion beyond remittances into broader cross-border financial services.

• ·Remitly trusted by millions of customers.
• ·Remitly evolving into a diversified cross-border financial services provider for consumers and businesses.

10-04-2026

Bruker Corporation announced that Falko Busse, Ph.D., President of the Bruker BioSpin Group, will transition duties on or around May 1, 2026, with employment terminating on October 31, 2026. A separation agreement provides for aggregate benefits of approximately $1,020,351, including severance, pro-rated bonus, and unused vacation payout, while Dr. Busse will forfeit all unvested equity awards. The agreement includes customary restrictive covenants, confidentiality, non-solicitation, and non-disparagement provisions.

• ·Separation agreement dated April 7, 2026, following agreement on April 6, 2026.
• ·Full text of Separation Agreement to be filed as exhibit to Form 10-Q for fiscal quarter ending June 30, 2026.

10-04-2026

Kalaris Therapeutics, Inc. announced on April 8, 2026, that Matthew Gall resigned as Chief Financial Officer, effective April 14, 2026. Brett Hagen, the existing Chief Accounting Officer, will assume the role of principal financial officer effective the same date, with no changes to his compensation or any disclosed conflicts of interest.

• ·Brett Hagen has served as Chief Accounting Officer since January 2019.
• ·Prior roles: Senior Director Finance and Accounting at Eloxx Pharmaceuticals (Feb-Aug 2018), VP Finance and Controller at Proteostasis Therapeutics (May 2016-Dec 2017), Controller at BIND Therapeutics (Jul 2014-May 2016).
• ·Mr. Hagen holds a B.A. from University of Minnesota, graduate degree in accounting from Wright State University, and graduate degree in finance from Suffolk University.
• ·No family relationships with officers/directors or interests under Item 404(a) of Regulation S-K.

10-04-2026

Magnite, Inc. announced on April 7, 2026, that Adam Soroca will cease serving as Chief Product Officer effective April 8, 2026, transitioning to an advisor role through May 15, 2026. In connection with his termination, Mr. Soroca is entitled to severance benefits under the Executive Severance and Vesting Acceleration Agreement, as described in the Company's Proxy Statement filed April 16, 2025. The filing was made on April 10, 2026.

10-04-2026

On April 6, 2026, the Board of Cherry Hill Mortgage Investment Corp approved the 2026 Executive Compensation Plan effective January 1, 2026, for key executives Jay Lown (President/CEO), Julian Evans (CIO), and Apeksha Patel (CFO), following the transition to internal management in November 2024. The plan includes base salaries of $900,000, $550,000, and $400,000 respectively, STIP cash bonuses with target opportunities of $360,000, $275,000, and $200,000, and LTIP equity awards with target values of $900,000, $550,000, and $400,000, benchmarked against peer REITs. Total target compensation opportunities are $2,160,000 for Lown, $1,375,000 for Evans, and $1,000,000 for Patel, with performance-based components tied to EAD ROE, relative share price to tangible book value, TSR, and individual goals.

• ·Plan approved based on Compensation Committee recommendation and benchmarking against peer group of public REITs similar in asset focus and size.
• ·STIP company metrics: 50% EAD ROE (non-GAAP: earnings available for distribution / average book value per share), 50% share price to tangible book value vs performance peer group.
• ·LTIP performance-based: 50% relative TSR vs peer group, 50% absolute TSR; first tranche January 1, 2026 to December 31, 2028.
• ·Time-based LTIP vests one-third annually over 3 years; performance-based vests at end of period upon certification.

10-04-2026

On April 7, 2026, Mark Eisner, MD, MPH, Executive Vice President and Chief Medical Officer of Vir Biotechnology, Inc., informed the company that he will step down from his role effective April 24, 2026. The company has initiated a search for a successor. No successor has been named, and no details on reasons for departure or compensatory arrangements were provided.

• ·Common stock: $0.0001 par value, trading symbol VIR on Nasdaq Global Select Market
• ·Company address: 1800 Owens Street, Suite 900, San Francisco, California 94158
• ·Filing signed by Marianne De Backer on April 10, 2026

10-04-2026

On April 6, 2026, Mark Stockslager resigned from his positions as Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer of Regional Health Properties, Inc., effective immediately, with no disagreement on operations, policies, or practices; he will continue in an advisory capacity for transition. Brent Morrison, the Company's Chairman, Chief Executive Officer, and President, assumed these roles on an interim basis until a successor is appointed, with no changes to his compensation. The filing references the Company's Form 10-K for the year ended December 31, 2025, for details on executive compensation and biographies.

• ·Filing date: April 10, 2026; earliest event date: April 6, 2026.
• ·No determination yet on changes to Mr. Stockslager’s compensation for advisory role.

10-04-2026

Exicure, Inc. appointed Yoontae Han as a director and to the Audit Committee on April 8, 2026, with Dongho Lee appointed as Chair of the Audit Committee; Han will receive a $20,000 annual retainer. On April 9, 2026, Young Seung Ko was appointed Chief Operating Officer, with an amended services agreement adding a $10,000 monthly fee to Innocircle Advisors Inc. No material interests or arrangements were disclosed for either appointment.

• ·Yoontae Han appointed effective April 8, 2026, until successor elected or earlier death, resignation, or removal.
• ·Young Seung Ko, age 50, has over 20 years of experience; previously CEO of AGEDB Technology Ltd. (Sep 2022-Mar 2025) and Director of Global Operations at Bitnine Global Inc. (Oct 2020-Sep 2024).
• ·No family relationships between Mr. Ko and any director or executive officer.

10-04-2026

On April 6, 2026, Gerald J. Maginnis, Director, Chairman of the Audit Committee, and member of the Compensation and Nominating and Corporate Governance Committees of InTest Corporation (INTT), notified the company he will not stand for re-election at the 2026 annual meeting of shareholders for personal reasons, including other professional commitments. His decision is unrelated to any disagreement with the company's operations, policies, or practices, and he will serve out his term until the annual meeting. The company expressed thanks for his service and contributions.

10-04-2026

Matthews International Corporation entered into an Employment and Transition Agreement with Steven D. Gackenbach, Group President, Memorialization, on April 8, 2026, under which he will serve full-time through September 30, 2026, with an annual base salary of $562,500, followed by a part-time Senior Advisor role starting October 1, 2026, through January 2, 2028, at 50% reduced salary. Mr. Gackenbach remains eligible for annual bonuses at a 60% target of base salary during both periods and restricted stock unit awards based on market benchmarks. The agreement includes provisions for change in control payments, termination scenarios, and post-employment restrictions like non-compete and non-solicitation.

• ·If Mr. Gackenbach elects to retire during Advisor Period, transitions to consultant arrangement for at least two years.
• ·Eligible for merit-based raise in January 2027 per company procedures.
• ·Agreement includes customary confidentiality, non-solicitation, non-competition, and non-disparagement obligations.

10-04-2026

John Leahy, a Board member of The Vita Coco Company, Inc. since 2019 and member of the Audit and Compensation Committees, has decided to retire and will not stand for reelection at the 2026 Annual Meeting of Stockholders on June 3, 2026, for personal reasons with no disagreements regarding operations, policies, or practices. He will continue in his roles until the meeting ends. Following his retirement, the Board size will reduce from 10 to 9 members.

• ·Date of earliest event reported: April 6, 2026
• ·Filing date: April 10, 2026

10-04-2026

Jeff Knight resigned as Chief Development and Operating Officer of Crinetics Pharmaceuticals, Inc. effective April 10, 2026, but simultaneously entered into a one-year Independent Consultant Agreement to provide operational and clinical development services through April 10, 2027, with an option for a six-month extension. Under the agreement, Knight will be compensated at $400 per hour for up to 20 hours per month, with reimbursement for pre-approved expenses; unvested equity will be forfeited, while vested stock options remain exercisable for three months post-consulting period. The agreement includes a mutual release of claims related to his departure.

• ·Consulting agreement may be renewed for an additional six months if mutually agreed in writing.
• ·Vested stock options exercisable until three months after end of consulting period or earlier termination for cause.
• ·Company agreed to extend indemnification rights to Knight during consulting period.

10-04-2026

On April 6, 2026, Matthew McBrady, a director of Axon Enterprise, Inc., notified the Board that he will not stand for re-election at the 2026 Annual Meeting of Shareholders and will serve until his term expires then. His decision was not due to any disagreement with the company's operations, policies, or practices. The Board expressed appreciation for his leadership and contributions to the company's growth.

• ·Report dated April 10, 2026, for event on April 6, 2026.

10-04-2026

Humana Inc. (NYSE: HUM) announced the election of Robert S. Field to its Board of Directors, effective immediately following the 2026 Annual Meeting of Stockholders. Field, Principal and Managing Member of ηMed Capital Management LLC focused on U.S. healthcare services, brings over two decades of healthcare investment experience from roles at Luxor Capital, McKinsey & Company, and Vinson & Elkins LLP. The appointment resulted from a comprehensive search process informed by shareholder engagement, including input from John Petry of Sessa Capital, aimed at board refreshment and strong governance.

• ·Field's expertise includes investment evaluation, risk oversight, capital allocation, and legal/regulatory dynamics in healthcare.
• ·Contact for investors: Lisa Stoner, (502) 580-2652, lstamper@humana.com; Media: Mark Taylor, (317) 753-0345, mtaylor108@humana.com.

10-04-2026

On April 6, 2026, Gary Kreitzer informed Innovative Industrial Properties, Inc. that he will retire from the Board and not stand for re-election at the 2026 annual meeting of shareholders. His decision is not due to any disagreement with the Company on operations, policies, or practices. Alan Gold, Executive Chairman, expressed gratitude for Mr. Kreitzer's dedicated service since the Board's inception.

• ·Company address: 1389 Center Drive, Suite 200, Park City, UT 84098
• ·Registrant's telephone number: (858) 997-3332

10-04-2026

Caterpillar Inc. announced CFO Andrew Bonfield's retirement effective October 1, 2026, after eight years marked by record achievements, including 2025 full-year sales and revenues of $67.6 billion and a Q4 2025 single-quarter record of $19.1 billion. Caterpillar veteran Kyle Epley, currently Senior Vice President of Global Finance Services, will assume the CFO role effective May 1, 2026, with Bonfield providing advisory support during the transition. Leadership expressed strong confidence in the seamless handover and Epley's deep experience to sustain profitable growth.

• ·Bonfield named 2025 CFO of the Year by the CFO Leadership Council and Chief Executive Group
• ·Announcement date: April 8, 2026; Filing date: April 10, 2026
• ·Primary business segments: Power & Energy, Construction Industries, Resource Industries

10-04-2026

Longeveron Inc. restored full base salaries and fees to its executive officers and Board members after a temporary 25-50% reduction effective February 16, 2026, following a financing closing on March 12, 2026. The Compensation Committee also approved RSU grants of 250,000 shares to each executive other than the CEO (who received 500,000 RSUs), vesting quarterly over three years commencing July 1, 2026, in recognition of their financing efforts. No declines or flat metrics reported in this update.

• ·Temporary compensation reductions implemented on or about February 16, 2026.
• ·Financing transaction closed as reported on Form 8-K dated March 12, 2026.
• ·RSU grants to be issued May 1, 2026.

10-04-2026

AppFolio, Inc. entered into a Second Amended and Restated Employment Agreement with President and CEO Shane Trigg on April 9, 2026, superseding the prior agreement from March 1, 2023. The agreement provides for at-will employment with a minimum annual base salary of $570,000, target annual bonus of 100% of base salary, and significant equity awards including $5,000,000 RSUs and $4,479,000 PSUs at target for FY2026, plus annual RSUs of $5,000,000 and formula-based PSUs for FY2027-2030. It also outlines enhanced severance benefits conditioned on release of claims, including up to 24 months base salary continuation in a corporate transaction scenario.

• ·Severance for termination without cause or good reason (outside corporate transaction): 18 months base salary, prorated bonus up to target, 12 additional months vesting acceleration on certain equity.
• ·Death/disability severance: 12 months base salary, full vesting of RSUs and PSUs up to target.
• ·Corporate transaction severance (within specified window): 24 months base salary, 200% bonus up to target, full vesting of RSUs/PSUs.
• ·Agreement filed as Exhibit 10.1.

10-04-2026

Orion S.A. disclosed that Director Mr. Michel Wurth announced on April 6, 2026, his decision not to stand for re-election at the 2026 annual general meeting due to increased responsibilities with other endeavors. This decision was not due to any disagreement with the company or the Board of Directors. The preliminary proxy statement for the Annual Meeting was filed with the SEC on April 10, 2026.

10-04-2026

Douglas Emmett, Inc. (NYSE: DEI) announced on April 10, 2026, the election of Mr. Andy Cohen to its Board of Directors. Mr. Cohen, Global Co-Chair of Gensler—the world’s largest architecture firm generating over $2 billion in revenue in 2025 with 60 offices and 6,500 professionals—brings 43 years of experience, including as Co-CEO from 2005 to 2024. No other changes or performance metrics were reported.

• ·Mr. Cohen served as Co-CEO of Gensler from 2005 to 2024.
• ·Mr. Cohen is a registered architect in 41 states and 3 Canadian provinces.
• ·Mr. Cohen is a Fellow of the American Institute of Architects and graduate of Pratt Institute.
• ·Gensler designs projects in over 100 countries.

10-04-2026

On April 10, 2026, Playboy, Inc. entered into retention agreements with its named executive officers—Ben Kohn (CEO and President), Marc Crossman (CFO and COO), Chris Riley (General Counsel and Secretary), and David Miller (President, Playboy Media & Brand)—to incentivize their continued service. The agreements acknowledge prior RSU grants as of April 8, 2026, of 645,161 shares to Kohn and 225,806 shares each to Crossman, Riley, and Miller, vesting on April 30, 2027. They also provide for identical RSU grants in 2027 (vesting April 30, 2028), subject to Compensation Committee approval, with potential cash conversion under limited circumstances and forfeiture if the executive resigns or is terminated for cause prior to issuance.

• ·RSUs granted as of April 8, 2026, previously disclosed on Forms 4 filed April 10, 2026
• ·2027 RSU grants subject to sole discretion of Compensation Committee
• ·Under limited circumstances per formulas in agreements, unissued 2027 RSUs may convert to cash payments

10-04-2026

Scott T. DeGhetto’s term as Hawaiian Electric Industries, Inc.'s Executive Vice President & Chief Financial Officer ended on April 1, 2026. On April 6, 2026, the company entered a one-year Consultant Services Agreement with him through Emberstone, LLC, for advisory services on financing and corporate projects, featuring a $200,000 monthly fee and a $1,350,000 special projects fee at term end, plus taxes. This supplements a previously disclosed $800,000 consulting payment through March 1, 2027.

• ·Agreement term ends April 5, 2027, unless terminated earlier
• ·Fees subject to applicable general excise or use taxes
• ·Fees prorated if terminated by company for Cause or by Mr. DeGhetto for any reason
• ·Reimbursement for reasonable out-of-pocket business expenses
• ·Details referenced in Item 5 of Form 10-Q filed November 8, 2024

10-04-2026

Pelthos Therapeutics Inc. (NYSE American: PTHS) announced John M. Gay as the new Chief Financial Officer effective April 10, 2026, succeeding Francis Knuettel II, who served in the role since July 2025. CEO Scott Plesha highlighted Gay's key contributions to the company's launch and recent capital raises, expressing excitement for his leadership in the next growth phase. The transition follows the merger with Channel Therapeutics Corporation and reflects continued commercial momentum for its dermatology portfolio.

• ·Pelthos is a commercial-stage biopharmaceutical company focused on cutaneous infectious disease products, with ZELSUVMI as the first prescription therapy approved for at-home treatment of Molluscum contagiosum.
• ·Prior to Pelthos, John M. Gay served as CFO of LNHC, Inc. (subsidiary of Ligand Pharmaceuticals) and in senior finance roles at Furiex Pharmaceuticals (acquired by Forest Laboratories).
• ·Investor contact: Mike Moyer, LifeSci Advisors (mmoyer@lifesciadvisors.com); Media: Kellie Walsh, (914) 315-6072.

10-04-2026

On April 7, 2026, Cibus, Inc. appointed Thomas Urban, 61, as a new member of its Board of Directors. Mr. Urban has extensive agribusiness experience, including founding Agribusiness Advisors in 2013, serving as CEO of CellFor, Inc. from 2004-2012, leadership roles at Pioneer Hi-Bred International and DuPont, and starting at Goldman Sachs. He will receive prorated annual compensation of a $60,000 cash retainer (payable semi-annually) and $90,000 equity grant under the 2017 Omnibus Incentive Plan, along with a standard indemnification agreement.

• ·No arrangements or understandings between Mr. Urban and any other persons pursuant to his appointment.
• ·Mr. Urban has no direct or indirect material interest in any transaction required to be reported under Item 404(a) of Regulation S-K.
• ·Compensation prorated for service through the upcoming annual meeting of shareholders.
• ·Entrepreneur in residence at the University of British Columbia since 2013.
• ·Education: Undergraduate from Middlebury College, MBA from Harvard Graduate School of Business.

10-04-2026

Eric Swider resigned from the Board of Directors of Trump Media & Technology Group Corp. effective immediately on April 6, 2026. The resignation did not arise from or relate to any dispute with management or the Board. The Company thanked Mr. Swider for his service.

• ·Form 8-K filed on April 10, 2026.
• ·Company principal executive offices: 401 N. Cattlemen Rd., Ste. 200, Sarasota, Florida 34232.

10-04-2026

Tenet Healthcare Corporation entered into a Retirement Transition Agreement with Paola Arbour, Executive Vice President and Chief Information Officer, providing for her retirement from her full-time role effective December 31, 2026, while continuing part-time in a non-executive capacity through April 1, 2028. Under the agreement, she will receive a weekly salary of $820, remain eligible for a 2026 bonus but not 2027, with equity awards continuing to vest and benefits including medical coverage and Executive Retirement Account service credit preserved through April 1, 2028. The agreement includes a general release of claims in favor of the Company, with a confirming release required from Ms. Arbour on April 1, 2028.

• ·Agreement dated April 9, 2026, filed on April 10, 2026 under Items 5.02 and 9.01.
• ·Securities: Common stock (THC, NYSE), 6.875% Senior Notes due 2031 (THC31, NYSE).

10-04-2026

Douglas Elliman Inc. amended employment agreements with Executive VP, Treasurer, and CFO J. Bryant Kirkland III and SVP, General Counsel, and Secretary Bradley H. Brodie on April 10, 2026, effective January 1, 2026 for salary increases. Kirkland's base salary rose to $650,000 with a 65% target bonus opportunity and a $150,000 one-time retention bonus; Brodie's base salary increased to $575,000 with a 50% target bonus. Severance terms were enhanced for both executives, including 12-month periods based on target bonuses rather than performance, with additional protections post-change in control.

• ·Kirkland severance: 12 months base + prorated target bonus for qualifying termination; post-change in control within 12 months: full target bonus + 12 months COBRA.
• ·Brodie severance: 12 months base + prorated target bonus for qualifying termination; post-change in control within 12 months: 1.5x base + full target bonus + 12 months COBRA.
• ·Amendments filed as exhibits in future periodic report.

10-04-2026

BJ’s Restaurants, Inc. announced the appointment of Ashley A. Van as Senior Vice President and Principal Accounting Officer effective May 11, 2026, with a base salary of $340,000, a target annual bonus opportunity of 55% of base salary, a $50,000 signing bonus, and an initial equity grant valued at $300,000. Ms. Van has prior experience at Reformation, Sweetgreen (NYSE: SG), El Pollo Loco (Nasdaq: LOCO), and other public companies. Effective the same date, J. Todd Wilson, the Chief Financial Officer, will cease serving as Principal Accounting Officer.

• ·Letter agreement dated April 7, 2026; filing dated April 10, 2026.
• ·Annual bonus multiplier ranges from 75% to 125% based on performance.
• ·Severance eligibility: 6 months base salary plus up to 6 additional months for years of service (max 12 months), plus COBRA equivalent payments.
• ·Initial equity vests in three equal annual installments starting July 15, 2027 (50% RSUs, 50% NSOs).
• ·Annual equity under 2024 Equity Incentive Plan.

10-04-2026

The Federal Home Loan Bank of New York's Board was informed that CFO Kevin Neylan will retire effective April 10, 2026, following prior disclosure on November 24, 2025. Neylan has agreed to extend his employment as CFO through April 30, 2026, and then serve as a consultant in that capacity through June 30, 2026. This ensures a smooth transition with no immediate vacancy.

• ·Signed by Donna Gordon, Chief Legal Officer, on April 10, 2026

10-04-2026

Solid Biosciences Inc. announced that director Ilan Ganot resigned from Class III of the Board effective April 10, 2026, at 4:00 p.m. ET, to achieve balance across board classes; simultaneously, the Board reduced Class III directors to three, increased Class I to three, and appointed Mr. Ganot to the Class I vacancy with a term expiring at the 2028 Annual Meeting. The change involves no compensation adjustments, and stockholders will be asked to ratify the appointment on an advisory basis at the 2026 Annual Meeting.

• ·Effective time: 4:00 p.m., Eastern Time, on April 10, 2026
• ·Class I term for Mr. Ganot expires at 2028 Annual Meeting of Stockholders
• ·Ratification sought on advisory basis at 2026 Annual Meeting of Stockholders